Whack-a-Mole: Testing an Intervention to Increase Melanoma Identification

Sponsor
University of Miami (Other)
Overall Status
Completed
CT.gov ID
NCT04069104
Collaborator
(none)
1,849
1
3.6
511.6

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate an interactive game designed to increase people's ability to identify cancerous moles.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: ABCD Information
  • Behavioral: UDS information
  • Behavioral: Standard (clinical) feedback
  • Behavioral: Motivational feedback

Study Design

Study Type:
Observational
Actual Enrollment :
1849 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
Whack-a-Mole: Testing an Intervention to Increase Melanoma Identification
Actual Study Start Date :
Nov 13, 2020
Actual Primary Completion Date :
Mar 3, 2021
Actual Study Completion Date :
Mar 3, 2021

Arms and Interventions

Arm Intervention/Treatment
ABCD training with standard feedback

Asymmetry, Border, Color, Diameter (ABCD) training message intervention with standard dermatological feedback

Behavioral: ABCD Information
The intervention condition includes exposure to a message emphasizing the ABCD strategy to identify malignant melanoma.

Behavioral: Standard (clinical) feedback
Feedback on mole identification task provided by a dermatologist.

ABCD training with motivational feedback

ABCD training message intervention with dermatological feedback and a motivational message

Behavioral: ABCD Information
The intervention condition includes exposure to a message emphasizing the ABCD strategy to identify malignant melanoma.

Behavioral: Motivational feedback
Feedback on mole identification task provided by a dermatologist plus exposure to a motivational fear appeal message designed to increase skin self exam intentions.

ABCD training with no feedback

ABCD message intervention with no feedback

Behavioral: ABCD Information
The intervention condition includes exposure to a message emphasizing the ABCD strategy to identify malignant melanoma.

UDS method training with standard feedback

Ugly Duckling Sign (UDS) method message intervention with dermatological feedback.

Behavioral: UDS information
The intervention condition includes exposure to a message emphasizing the UDS strategy to identify malignant melanoma.

Behavioral: Standard (clinical) feedback
Feedback on mole identification task provided by a dermatologist.

UDS method training with motivational feedback

UDS message intervention with dermatological feedback and a motivational message.

Behavioral: UDS information
The intervention condition includes exposure to a message emphasizing the UDS strategy to identify malignant melanoma.

Behavioral: Motivational feedback
Feedback on mole identification task provided by a dermatologist plus exposure to a motivational fear appeal message designed to increase skin self exam intentions.

UDS training with no feedback

UDS message intervention with no feedback.

Behavioral: UDS information
The intervention condition includes exposure to a message emphasizing the UDS strategy to identify malignant melanoma.

ABCD-F training with standard feedback

ABCD-F intervention with dermatological feedback.

Behavioral: ABCD Information
The intervention condition includes exposure to a message emphasizing the ABCD strategy to identify malignant melanoma.

Behavioral: UDS information
The intervention condition includes exposure to a message emphasizing the UDS strategy to identify malignant melanoma.

Behavioral: Standard (clinical) feedback
Feedback on mole identification task provided by a dermatologist.

ABCD-F training with motivational feedback

ABCD-F intervention with dermatological feedback and a motivational message.

Behavioral: ABCD Information
The intervention condition includes exposure to a message emphasizing the ABCD strategy to identify malignant melanoma.

Behavioral: UDS information
The intervention condition includes exposure to a message emphasizing the UDS strategy to identify malignant melanoma.

Behavioral: Motivational feedback
Feedback on mole identification task provided by a dermatologist plus exposure to a motivational fear appeal message designed to increase skin self exam intentions.

ABCD-F training with no feedback

ABCD-F intervention with no feedback.

Behavioral: ABCD Information
The intervention condition includes exposure to a message emphasizing the ABCD strategy to identify malignant melanoma.

Behavioral: UDS information
The intervention condition includes exposure to a message emphasizing the UDS strategy to identify malignant melanoma.

No message intervention with standard feedback

No message intervention, but with dermatological feedback.

Behavioral: Standard (clinical) feedback
Feedback on mole identification task provided by a dermatologist.

No message intervention with motivational feedback

No message intervention, but with dermatological feedback and a motivational message.

Behavioral: Motivational feedback
Feedback on mole identification task provided by a dermatologist plus exposure to a motivational fear appeal message designed to increase skin self exam intentions.

No message intervention with no feedback

No message intervention and no feedback. True control.

Outcome Measures

Primary Outcome Measures

  1. Mole identification accuracy [Day 2]

    Mole identification accuracy will be reported as the amount of mole correctly identified as either melanoma or typical nevi

Secondary Outcome Measures

  1. Skin Self Exam Intentions [Day 2]

    Self-report measure of intentions to perform a skin self exam. Quantified using a single item indicator with scores ranging from 1-7 with higher scores indicating greater intentions to perform a skin self exam to detect potential melanomas.

  2. Intentions to see a Dermatologist [Day 2]

    Self-report measure of intentions to schedule an appointment with a dermatologist to receive a skin cancer exam. Quantified using a single item indicator with scores ranging from 1-7 with higher scores indicating greater intentions to schedule an appointment with a dermatologist.

  3. Skin Self Exam Attitudes [Day 2]

    Self-report measure of attitudes towards skin cancer exams. Quantified using the mean of the self report scale with scores ranging from 1-7 with higher scores indicating more positive attitudes towards skin self exams.

  4. Skin Self Exam Beliefs [Day 2]

    Self-report measure of beliefs towards skin cancer exams. Quantified using the mean of the self report scales for perceived susceptibility, perceived severity, perceived self-efficacy, and perceived response efficacy with scores ranging from 1-7 with higher scores indicating more strongly held beliefs about skin self exams.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Resident of U.S.

  • At least 18 years old

  • Capable of reading English

  • Member of panel assembled by survey provider

Exclusion Criteria:
  • Individuals under 18 years old

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Miami Coral Gables Florida United States 33146

Sponsors and Collaborators

  • University of Miami

Investigators

  • Principal Investigator: Nicholas Carcioppolo, PhD, Study Co-Principal Investigator
  • Principal Investigator: Soyoon Kim, PhD, Study Co-Principal Investigator

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Nicholas Carcioppolo, Associate Professor, University of Miami
ClinicalTrials.gov Identifier:
NCT04069104
Other Study ID Numbers:
  • 20190153
First Posted:
Aug 28, 2019
Last Update Posted:
Oct 25, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Nicholas Carcioppolo, Associate Professor, University of Miami
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 25, 2021